Sartorius Stedim Biotech S.A.

ENXTPA:DIM Stock Report

Market Cap: €18.3b

Sartorius Stedim Biotech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Rene Faber

Chief executive officer

€790.0k

Total compensation

CEO salary percentage68.4%
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure8.5yrs

Recent management updates

Recent updates

Sartorius Stedim Biotech's (EPA:DIM) Weak Earnings May Only Reveal A Part Of The Whole Picture

Oct 25
Sartorius Stedim Biotech's (EPA:DIM) Weak Earnings May Only Reveal A Part Of The Whole Picture

Sartorius Stedim Biotech S.A.'s (EPA:DIM) Share Price Not Quite Adding Up

Oct 15
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Share Price Not Quite Adding Up

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Aug 11
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Jul 21
Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Jul 12
Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

May 13
Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Apr 21
Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Apr 20
With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Feb 19
Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Dec 22
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

CEO Compensation Analysis

How has Rene Faber's remuneration changed compared to Sartorius Stedim Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

€161m

Jun 30 2024n/an/a

€170m

Mar 31 2024n/an/a

€255m

Dec 31 2023€790k€540k

€310m

Sep 30 2023n/an/a

€460m

Jun 30 2023n/an/a

€635m

Mar 31 2023n/an/a

€717m

Dec 31 2022€578k€288k

€876m

Sep 30 2022n/an/a

€681m

Jun 30 2022n/an/a

€625m

Mar 31 2022n/an/a

€559m

Dec 31 2021€901k€396k

€414m

Sep 30 2021n/an/a

€523m

Jun 30 2021n/an/a

€469m

Mar 31 2021n/an/a

€398m

Dec 31 2020€742k€396k

€336m

Sep 30 2020n/an/a

€299m

Jun 30 2020n/an/a

€255m

Mar 31 2020n/an/a

€254m

Dec 31 2019€784k€425k

€235m

Compensation vs Market: Rene's total compensation ($USD826.97K) is below average for companies of similar size in the French market ($USD4.62M).

Compensation vs Earnings: Rene's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Rene Faber (49 yo)

1.8yrs

Tenure

€790,000

Compensation

Dr. Rene Faber serves as Head of Bioprocess Solutions Division and Member of the Executive Board at Sartorius Aktiengesellschaft since January 01, 2019. He serves as Chief Executive Officer at Sartorius St...

Board Members

NamePositionTenureCompensationOwnership
Rene Faber
CEO & DIrector5.8yrs€790.00kno data
Joachim Kreuzburg
Non-Executive & Non-Independent Chairman17.5yrs€693.15k0.000010%
€ 1.8k
Lothar Kappich
Director7.3yrs€84.00k0%
€ 0
Henri Riey
Director17.5yrs€56.00k0.000010%
€ 1.8k
Pascale Boissel
Independent Director5.8yrs€93.00k0%
€ 0
Anne-Marie Graffin
Lead Independent Director9.7yrs€91.00k0.000010%
€ 1.8k
Susan Dexter
Independent Director9.7yrs€84.00k0.000010%
€ 1.8k
Romaine Fernandes
Employee Representative Non - Executive Director1.2yrsno data0%
€ 0

8.5yrs

Average Tenure

61yo

Average Age

Experienced Board: DIM's board of directors are considered experienced (8.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 07:54
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sartorius Stedim Biotech S.A. is covered by 31 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stéphan DubosqArkeon Finance
Charles Pitman-KingBarclays
Scott BardoBerenberg